AB1086 A PROMISING GLYCOBIOMARKER TO PREDICT CLINICAL CHARACTERISTICS AND DISEASE ACTIVITY OF PATIENTS WITH JUVENILE LUPUS ERYTHEMATOSUS PATIENTS: PRELIMINARY RESULTS
D. Santos Oliveira, I. Brito(Universidade do Porto), Rui Farinha(Hospital de São João), Salomé S. Pinho(i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto), Rafaela Nicolau(Centro Hospitalar Tondela-Viseu), Tiago Beirão(Administração Regional de Saúde de Lisboa e Vale do Tejo), F. Aguiar(Universidade do Porto), Inês Alves(Arkansas Children's Hospital), F. R. Martins(Algarve Biomedical Center), M Rodrigues(Universidade do Porto), Sara Ganhão(Hospital de São João), Sara Babo Martins(Universidade do Porto)
Cited by 0
Related Papers
Dysregulation of T cell receptor N-glycosylation: a molecular mechanism involved in ulcerative colitis
|Human Molecular Genetics|2013|70
A unique serum IgG glycosylation signature predicts development of Crohn’s disease and is associated with pathogenic antibodies to mannose glycan
|Nature Immunology|2024|52
The role of glycans in health and disease: Regulators of the interaction between gut microbiota and host immune system
|Seminars in Immunology|2024|21
Predictors of cardiac involvement in idiopathic inflammatory myopathies
|Frontiers in Immunology|2023|18